Click to Share
 

Biomarkers Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

12386153
By Cambridge Healthtech Institute
Leading Pharma, Biotech and Academic Researchers Unite to Share Findings for the Role of Circulating microRNA, Exosomes and Microvesicles, Long Non-Coding RNA and Extracellular RNA in Disease
By Critical Path Institute
The Critical Path Institute (C-Path) announced today that the U.S.
By Insight Pharma Reports
Understand the market growth of biomarkers, advantages, disadvantages, and validation techniques
By Insight Pharma Reports
Understand the market growth of biomarkers, advantages, disadvantages, and validation techniques
By Insight Pharma Reports
Understand the market growth of biomarkers, advantages, disadvantages, and validation techniques
By Insight Pharma Reports
Understanding the applications of biomarkers in the research community
12350010
By Visiongain
LONDON, UK, 18TH July 2014: A new report by visiongain calculates that the global prostate cancer therapeutics market will reach $7bn in 2014 with revenue showing strong growth to 2024.
12293372
By SMi Group
Imaging allows us to answer questions that we did not know the answer to before. For example, it can help determine the composition of the tumour, clinical evaluation of patients and evaluation of new treatments.
By Aseptika Ltd (Activ8rlives)
Aseptika Ltd, is developing home-based rapid and quantitative test for bacterial respiratory infections in patients with Cystic Fibrosis (CF). Volunteers from Papworth Hospital NHS Foundation Trust are now participating in the clinical trial.
12052399
By SMi Group
It will bring you the latest developments from toxicity testing to compound screening and first-in-man studies to companion diagnostic assays, stay competitive with fresh insights from companies at the cutting edge of biopharmaceutical development.
11975208
By SMi Group
Drawing on advances in genomics, translational medicine and clinical trial design, SMi’s sixth annual Biomarkers Summit held on 16th &17th January 2013 London brings you the latest developments in this field.
11912462
By SMi Group
Paving the way of using AD biomarkers as supportive evidence of disease modifying treatment effects
11815688
By SMi Group
Technical developments in Immuno-PET and TKI-PET and their clinical potential
By Cambridge healthtech Institute
CHI confirms new speakers for its keynote session on cancer clinical trials in the era of personalized medicine lead by Roche Holding AG, UCSF Helen Diller Family Comprehensive Cancer Center, and Samuel Oschin Comprehensive Cancer Institute.

All Press Releases

By Research Beam
Cardiac Biomarkers are protein substances released into the blood stream from damaged heart muscles. These are the biological parameters that are used to detect the presence of cardiovascular diseases.
By Aseptika
Aseptika Limited today announced that it has been granted a patent in the United States (US) protecting its invention for a test for respiratory infections.
12386153
By Cambridge Healthtech Institute
Leading Pharma, Biotech and Academic Researchers Unite to Share Findings for the Role of Circulating microRNA, Exosomes and Microvesicles, Long Non-Coding RNA and Extracellular RNA in Disease
By Critical Path Institute
The Critical Path Institute (C-Path) announced today that the U.S.
By Insight Pharma Reports
Understand the market growth of biomarkers, advantages, disadvantages, and validation techniques
By Insight Pharma Reports
Understand the market growth of biomarkers, advantages, disadvantages, and validation techniques
By Insight Pharma Reports
Understand the market growth of biomarkers, advantages, disadvantages, and validation techniques
By Insight Pharma Reports
Understanding the applications of biomarkers in the research community
12350010
By Visiongain
LONDON, UK, 18TH July 2014: A new report by visiongain calculates that the global prostate cancer therapeutics market will reach $7bn in 2014 with revenue showing strong growth to 2024.
By SBH Sciences
(Natick, MA, USA)  July 1, 2014. SBH Sciences, an innovative pre-clinical contract research organization, announced today that they have increased their service offerings through the addition of a newly introduced immunoassay-testing platform, the...
By Pathology Diagnostics Ltd
Immunotherapies were one of the highlights of the ASCO 2014 meeting.
By Pharmatech Inc.
Exciting new opportunities present themselves for cancer patients and the clinical trials industry.
12293372
By SMi Group
Imaging allows us to answer questions that we did not know the answer to before. For example, it can help determine the composition of the tumour, clinical evaluation of patients and evaluation of new treatments.
By Kalorama Information
The global medical biomarker market is valued at about $25.9 billion for 2013, an increase of 10.2% since last year, according to an estimate from Kalorama Information.
By Aseptika Ltd
Aseptika today announced that it has been granted a patent in the UK protecting its invention for a test for lung infections.
By Burke Medical Research Institute
Ava Weibman won a $4,000 Summer Student Fellowship from the Parkinson’s Disease Foundation (PDF) and a 10-week laboratory experience in Burke Medical Research Institute’s Laboratory for Neuronal Specification.
By Activ8rlives (Aseptika Ltd)
Activ8rlives announces a novel motivational programme for its users, utilising its integrated medals system, to reward being consistently active.
By Aseptika Ltd (Activ8rlives)
Aseptika Ltd, is developing home-based rapid and quantitative test for bacterial respiratory infections in patients with Cystic Fibrosis (CF). Volunteers from Papworth Hospital NHS Foundation Trust are now participating in the clinical trial.
12052399
By SMi Group
It will bring you the latest developments from toxicity testing to compound screening and first-in-man studies to companion diagnostic assays, stay competitive with fresh insights from companies at the cutting edge of biopharmaceutical development.
11975208
By SMi Group
Drawing on advances in genomics, translational medicine and clinical trial design, SMi’s sixth annual Biomarkers Summit held on 16th &17th January 2013 London brings you the latest developments in this field.
By Biotech Support Group
NuGel™ Glycoprotein Enrichment PBA product is ideal for mining glycoproteins and represents a new paradigm for biomarker discovery from glycoproteins.
By Visiongain
A new report by visiongain predicts that the global market for biomarkers will be worth $15.29 billion in 2012.
11912462
By SMi Group
Paving the way of using AD biomarkers as supportive evidence of disease modifying treatment effects
By Rosa & Co
Modeling analysis enables development of clinical markers for beta cell mass.
11815688
By SMi Group
Technical developments in Immuno-PET and TKI-PET and their clinical potential
By SMi Group
Join us on the 14th and 15th March 2012 at the Copthorne Tara Hotel to gain top tips from experienced industry figures discussing ways in which to develop drugs in a clever way with reduced production time
By Camrbridge Healthtech Institute
Cambridge Healthtech Institute's 8th Annual Translational Science Event Only 7 Weeks Away! Advance Registration Discount expires Friday, January 13th!
By Cambridge Healthtech Institute
Cambridge Healthtech Institute to Hold Inaugurual Next-Generation Pathology Symposia at 19th International Molecular Med Tri-CON 2012.
By SMi Group
This Biomarkers Summit 2012 will provide a unique opportunity for debate and problem solving for key challenges facing the biomarkers fields as well as hearing from leading experts in this rapidly-evolving area.
By GTC Conference
Pharmaceutical industry decision-makers, scientists, researchers, technology developers and investors will gather in one location at GTC’s Biomarker Summit 2012, March 15-16 in San Diego, CA.

Page:
Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share